School of Medicine
Showing 5,961-5,970 of 13,008 Results
-
Shin-Huei Kuo, M.D., M.S.
Visiting Scholar, Genetics
BioDr. Kuo is a Visiting Scholar in the Department of Genetics at Stanford University School of Medicine and an attending physician in the Division of Infectious Diseases at Kaohsiung Medical University Chung-Ho Memorial Hospital in Taiwan. Her clinical and research interests include HIV care, comorbidities, and prognosis modeling. At Stanford, she collaborates with faculty in the Snyder Lab to explore precision medicine approaches to infectious diseases and inflammaging.
-
WILLIAM T. KUO, MD, FSIR, FCCP, FSVM, FACR, FCIRSE
Professor of Radiology (Interventional Radiology)
Current Research and Scholarly Interests1) LASER-ASSISTED AND COMPLEX IVC FILTER RETRIEVAL
2) CATHETER-DIRECTED THERAPY FOR ACUTE PULMONARY EMBOLISM
3) INTERNATIONAL PE REGISTRY
4) IVC FILTER REGISTRY
5) ENDOVASCULAR TREATMENT OF CAVAL AND DEEP VENOUS THROMBOSIS -
Clair Mariam Kuriakose
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioClair Kuriakose is a Physician Assistant with a clinical background in Pediatric Surgery. She joined Stanford September 2014 as the first Manager of Advanced Practice with the Center for Advanced Practice and officially transitioned to the Executive Director of Advanced Practice on August 2017. Clair is passionate about the value advanced practice providers bring to the complex and ever-changing healthcare industry and truly enjoys collaborating with the various Advanced Practice Providers in the organization to ensure the best care for our patients.
-
Allison W. Kurian, M.D., M.Sc.
Colleen Haas Chair in the School of Medicine, Professor of Medicine (Oncology) and of Epidemiology and Population Health
Current Research and Scholarly InterestsI aim to understand cancer burden and improve treatment quality at the population level. I have a strong focus on genetic risk assessment and precision oncology. I lead epidemiologic studies of cancer risk factors, clinical trials of novel approaches to genetic testing and cancer risk reduction, and decision analyses of strategies to optimize cancer outcomes.
